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doi:10.1016/j.jfma.2011.11.002Tuberculosis (TB) is an important public health issue in Taiwan and worldwide. Taiwan has
made major progress in combating TB in the past 40 years. However, childhood TB still consti-
tutes a significant challenge in disease control. From January to mid December 2011, 369 new
cases of pediatric TB were confirmed. The relatively low case number and variable clinical
presentations made it difficult for early detection. Latent TB infections in children also pose
further complexity in clinical management. Knowledge of the clinical features of active and
latent TB infection is crucial for efficient TB control.
Copyright ª 2011, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Tuberculosis (TB) is the disease caused by the Mycobacte-
rium tuberculosis complex, which includes M tuberculosis,
M bovis, and M africanum. Childhood TB comprisesof Pediatrics, National Cheng
Hospital, No.138, Sheng-Li
du.tw (C.-C. Liu).
ight ª 2011, Elsevier Taiwan LLCapproximately 15e20% of all cases, increasing up to 40% in
some high TB burden countries.1,2 In Taiwan, there were
66.7 TB cases per 100,000 population in 2003, while in the
U.S., according to the Centers for Disease Control and
Prevention, there were 5.1 cases per 100,000 population. In
the past 40 years, Taiwan has made tremendous progress in
combating TB. In 1948, 18,000 Taiwanese people died from
TB; in 1955, the number shrank to 7,000. After 1997, the
death rate of TB per 10,000 people was 7e8. Overall, the
death rate of TB has been decreasing while the incidence
has not risen. Actually, due to the new medicines for TB,
the cure rate is about 100%.3 Analysis of data from Taiwan’s& Formosan Medical Association. All rights reserved.
738 T.-S. Ho et al.National Tuberculosis Registry showed that incidence of TB
in persons <20 years of age was 9.61/100,000 person-years,
biphasic, and age-relevant, with a major peak in persons
just above 12 years. Aboriginal children were 8.1e17.4
times more likely to have TB than non-aboriginal children.4
TB transmission occurs mostly between close contacts,
especially in the household. Approximately 30% of heavily
exposed persons will become infected. Moreover, infection
does not necessarily lead to disease. Childhood TB should
be seen as a spectrum of M tuberculosis exposure, from
infection to disease. Primary infection may stay latent or
proceed immediately to primary active TB disease or
disease years later (secondary active TB). Several factors
influence latent TB infection progression to active disease,
including age, nutritional, vaccination, and immune sta-
tus.5e8 In 5% of persons with latent infection, active disease
will develop within 2 years.9 Only 5e10% of immunocom-
petent children progress from TB infection to disease.10
Primary infection before 2 years of age frequently pro-
gressed to serious disease within 1 year without significant
prior symptoms. Primary infection between 2 years and
10 years of age rarely progressed to serious disease, and
such progression was associated with significant clinical
symptoms. Primary infection after 10 years of age
frequently progressed to adult-type disease.11 Early effec-
tive intervention in this group will reduce the burden of
cavitating disease and associated disease transmission in
the community. Vaccination with Bacillus Calmette-Guerin
(BCG) is the most widely used preventive strategy,
although studies have shown highly variable protection.12
BCG vaccination seems to offer significant protection
against disseminated (miliary) disease and TB meningitis in
very young children but no protection against adult-type
TB.13Figure 1 Numbers of confirmed childhood and adult tuberculo
Notifiable Infectious Disease Statistics System (NIDSS), Centers forBefore microbiological confirmation, clinical diagnosis
of childhood TB frequently rests on the triad of (1) close
contact with an adult source case, (2) a positive tuberculin
skin test (TST) and/or interferon-gamma release assay
(IGRA), and (3) signs suggestive of TB on chest radiograph.14
The most helpful symptoms suggesting childhood TB
include: (1) persistent, nonremittent cough or wheeze for
more than 2 weeks, (2) documented failure to thrive or
weight loss despite food supplementation, and (3) fatigue
or reduced playfulness.15 TB treatment aims to cure the
individual patient with minimal adverse effects. From
a public health perspective, it is important to rapidly
terminate transmission and prevent the emergence of drug
resistance. The success of three drugs (isoniazid, rifampin,
and pyrazinamide) during the 2-month intensive phase and
two drugs (isoniazid and rifampin) during the 4-month
continuation phase for pediatric patients is well estab-
lished.16 However, higher drug dosages are now recom-
mended for treatment of childhood TB, based on
pharmacokinetic evidence.17Is latent TB infection (LTBI) true LTBI?
Recent studies in Taiwan showed that the increase in
childhood TB may be associated with the increase in the
incidence of the disease in adults (Fig. 1).4,18 Children with
household exposure to a sputum smear-positive index case
experienced the greatest risk of becoming infected and of
developing subsequent disease.5 By identifying and treating
infectious sources, usually adults can reduce the risk of
TB exposure in children. Children and adolescents are at
higher risk for progression to TB disease than adults. Most
cases of progression to TB disease occur within 2e12sis (TB) cases per year in Taiwan, 2003e2010. Adapted from
Diseases Control, Taiwan.
Figure 2 Is latent tuberculosis infection (LTBI) true LTBI? A 3-
year-old girl with TB exposure history showed coarsening of
bilateral peribronchovascular bundles and increased lung
markings in the right lower lung. Two of three consecutive
gastric aspirate cultures were positive for Mycobacterium
tuberculosis.
Childhood TB in Taiwan 739months of initial infection.10 Child contacts of a patient
with TB must be evaluated for TB with a history, physical
exam, chest radiograph, and TST.19 LTBI is defined as M
tuberculosis complex infection in a person who has a posi-
tive TST or IGRA result, no physical findings of disease, and
chest radiograph findings that are normal or reveal
evidence of healed infection (e.g., calcification in the lung,
hilar lymph nodes, or both).20 In 2009, as part of the “TB
half” campaign, Taiwan started an LTBI treatment program
for children younger than 13 years. Children who had TB
contact history are advised to visit the LTBI clinic island-
wide and have isoniazid (INH) prophylaxis treatment.21
According to the guideline from the Centers for Disease
Control of Taiwan, a child with positive TB contact history is
considered to have latent TB infection if there was no
abnormality in a chest radiograph. However, it is dangerous
to exclude the possibility of active TB disease only by imageFigure 3 Primary tuberculosis (TB) infections with adenitis. A 22-
vaccination. Her grandmother was diagnosed with pulmonary TB. Sh
skin test showed induration larger than 40 mm with bulla formatio
calcifying lymph nodes (arrow) at right paratrachea, pretrachea, sstudies. In the setting of LTBI, chest radiographs are usually
normal or show coarsening of bilateral peribronchovascular
bundles (Fig. 2) but may show dense nodules with calcifi-
cations, calcified nonenlarged regional lymph nodes, or
pleural thickening. Obtaining expectorated sputum from
children is difficult and its examination gives low yield (15%
or less for smear and 30% or less for culture).14,22 In our
practice, children under 5 years of age with close contact
history (i.e., index cases are parents, grandparents, or
primary caregivers) are encouraged to have three gastric
aspirates for Mycobacterium cultures in outpatient clinics
before starting INH prophylaxis. If the culture results are
positive for M tuberculosis, INH prophylaxis would be
replaced by three-combination therapy with isoniazid,
rifampin, and pyrazinamide. Increasing INH-resistant TB is
an important issue in such a program, and recent studies
also suggested that the recommended treatment for latent
TB, 9 months of isoniazid, is both more expensive and
less effective than rifampin. Rifampin should be considered
for children with latent TB infection when the risk of
isoniazid resistance exceeds 11%.23 Because current LTBI
policy in Taiwan covers only TB contacts younger than 13
years, adolescent contacts were not included in the isoni-
azid chemoprophylaxis. However, teenagers and children
younger than 5 years constitute the majority of pediatric
TB.4 We recommend that the LTBI policy should include
such age groups.
Primary pulmonary TB disease
Primary TB is seen in patients not previously exposed to M
tuberculosis. It is most common in infants and children and
has the highest prevalence in children less than 5 years of
age.24 Primary uncomplicated hilar adenopathy remains the
most common disease manifestation in children and is
usually regarded as the hallmark of primary TB (Fig. 3).25,26
In children infected with M tuberculosis, a primary focus of
infection will form (e.g., the Ghon focus on the lung). The
subsequent recruitment of the cell-mediated immune
response will result in regional or general adenopathies
depending on the dissemination of infection. The upper
lobes drain to ipsilateraleparatracheal nodes, whereas the
rest of the lung drains to perihilar and subcarinal nodes,month-old girl had not received Bacillus Calmette-Gue´rin (BCG)
e had no fever, cough, or changes in bodyweight. (A) Tuberculin
n. (B) The chest computerized tomography (CT) showed bulky
ubcarina, and bilateral hilum.
Figure 4 Primary tuberculosis (TB) infections: pleuritis with pleural effusion. (A) A 12-year-old boy was referred to our hospital
because of massive pleural effusion without response to conventional antibiotics therapy. (B) There was no significant lung
parenchyma involvement in the follow-up radiograph (after 6-month anti-TB treatment). Pleural effusion culture yielded Myco-
bacterium tuberculosis despite negative smear results. His grand-aunt was also diagnosed with pulmonary TB.
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complex is represented by both the Ghon focus, with or
without some overlying pleural reaction, and the affected
regional lymphnodes.14,27,28 Development of a reaction to
purified protein derivative (PPD) depends on an adequate
cell-mediated immune response. A positive PPD only indi-
cates that someone is infected. It does not give you any
information on the time of acquisition, latency, or activity
of TB disease. Abnormal radiographs have usually been the
standard to differentiate infection and disease. However, it
is challenging to diagnose subtle adenopathies in radio-
graphs, even for experienced pediatricians.29 Computed
tomography (CT) of the chest would be useful to further
define the anatomy in cases where findings in plain radio-
graphs are equivocal. Findings in children with suspected
primary pulmonary TB include multiple lymph nodes
(Fig. 3), ‘‘ghost-like’’ ring enhancement, and bronchialFigure 5 Secondary (post-primary) pulmonary tuberculosis. A 16
during the previous 6 months. (A) On admission, the chest X ra
cavitations over right upper lobe and upper segment of right lower
showed bronchiectasis with bronchial wall thickening and a so-callcompression; calcifications have been seen in 15e20% of
cases.30 Primary and secondary TB is also thought to have
characteristic radiographic and clinical features: primary
TB is said to be characterized by lower lobe disease,
adenopathy, and pleural effusions, and termed atypical,
whereas secondary or reactivation TB is associated with
upper lobe disease and cavitations termed typical.31
Pleural effusions complicate 2e38% of cases of pulmo-
nary TB in children, usually unilaterally (Fig. 4).32 Primary
pulmonary TB disease with pleural effusion is often found in
the absence of pulmonary parenchyma disease. Secondary
(post primary) pulmonary disease associated with pleural
involvement is characteristically associated with focal
parenchymal disease.33 The most common symptoms are
thoracic pain, cough, fatigue, shortness of breath, and
anorexia. The findings on physical examination can mimic
bacterial pneumonia,with dullness to percussion, diminished-year-old male had a chronic cough and lost 10 kg bodyweight
y showed patchy, poorly defined consolidation with multiple
lobe (posterioreanterior view). (B) Computed tomography (CT)
ed ‘‘signet ring sign’’ (arrow).
Childhood TB in Taiwan 741breath sounds, and fever. Pleural fluid is rarely acid fast
bacillus (AFB) smear-positive, and cultures are positive in
only 20e40% of cases.34Secondary (post-primary) pulmonary TB
disease
Secondary pulmonary disease usually presents during
adolescence and is most common in areas endemic for
TB and in HIV-infected patients. Symptoms include weight
loss, fever, productive cough, hemoptysis, and night sweats.
Findings on physical examination may be minimal. Radio-
graphic findings can overlap with those seen in primary
disease (Fig. 5).31 Radiographic features of secondary TB
include patchy, poorly defined consolidation for the upper
lobes and cavitations (about half of the patients) in the
absence of lymphadenopathy.35e37 Chest CT shows tree-in-
bud opacities and traction bronchiectasis, particularly of
the upper lobes, and bronchial stenosis is seen in 10e40% of
patients with active TB.24
Localized pleurisy overlying a peripheral Ghon focus was
common. Limited adhesions developed between the visceralFigure 6 Secondary pulmonary tuberculosis (TB) with pleural ef
having had a 3-day fever. He had a chronic cough for 3 months. His g
(A) On admission, chest radiograph showed right upper lung patches
(CT) showed right apical lung cavitations, (C) right upper lung b
opacities, and (D) local pleural thickening and effusion. Pleural
analysis. (B) Follow-up radiographs 6 months after complete anti-Tand parietal pleura, but this did not cause symptoms or lung
function abnormality.11 Effusions were rare in children
under 5 years of age and were most common in adolescent
boys.34 Pleural effusions occur most often in primary TB but
are seen in approximately 18% of patients with secondary
TB; they are usually small and associated with parenchymal
disease. The pleura may become thickened, which can
result in a tuberculous empyema (Fig. 6) and an associated
risk of developing a bronchopleural fistula. Residual pleural
thickening and calcification may also occur.24
Central nervous system (CNS) TB infection
Involvement of the CNS is seen in approximately 5% of
patients with TB. CNS TB can manifest in a variety of
forms, including tuberculous meningitis, tuberculomas,
tuberculous brain abscesses, tuberculous cerebritis, and
miliary TB.38e42 The most common complication of TB
meningitis is communicating hydrocephalus, followed by
ischemic infarcts (20e40%) and cranial nerve involvement
(17e70%).43e45 CNS TB most commonly presents 2e6
months after primary infection, and almost half of patients
are under 2 years of age.46 Chest radiographs are abnormal infusion. A 17-year-old male visited the emergency department
randfather was diagnosed with pulmonary TB 6 months earlier.
with parapneumonic opacities (arrows). Computed tomography
ronchiectasis with multifocal consolidation and “tree-in-bud”
fluid was positive for Mycobacterium tuberculosis in TB-PCR
B treatment showed complete resolution.
Figure 7 Tuberculosis (TB) involving the central nervous system (CNS). A 14-year-old girl was diagnosedwith pulmonary TB 2months
before admission. She visited our emergency department because of neck stiffness and fever for 3 days. (A) Chest radiographs at
admission showed patchy, poorly defined consolidation for the upper lobes, which are characteristic of secondary pulmonary TB.
Sputum smears were heavily positive for acid-fast bacilli and culture positive for Mycobacterium tuberculosis thereafter. Magnetic
resonance imaging (MRI) 2 months later showed cerebritis at left basal ganglia, left thalamus, left cerebellar peduncle, left midbrain,
and left pons. (B) T2-weighted MRI showed the presence of granuloma, a so-called “paradoxical response”.
742 T.-S. Ho et al.almost 90% of children with CNS TB (Fig. 7). The most
common findings include hilar or mediastinal adenopathy,
pulmonary infiltrates, and miliary disease. TB meningitis
is characterized by a cerebrospinal fluid analysis with pleo-
cytosis, high protein, and hypoglycorrhacia.47 AFB stains are
positive in only 10e30% of patients, and culture yield is
somewhat higher (30e70%) if 5e15 cm3 of cerebrospinal fluid
is cultured.48 Gastric aspirates cultures are positive in
approximately 10% of children with TB meningitis.41,46
Tuberculomas and meningitis may coexist in up to 10% of
cases. The clinical and neuroimaging features of tuber-
culoma are variable and may pose a diagnostic challenge in
the absence of systemic TB or tuberculous meningitis.49 They
appear radiographically as hyperdense, rim-enhancing
lesions ranging from 1 cm to 5 cm in maximum dimension.
Whereas adults commonly have multiple supratentorial
lesions, single infratentorial lesions are more common in
children.50 Tuberculomas can also either develop or enlarge
paradoxically after the initiation of antimycobacterial
therapy. A paradoxical response is defined as the clinical or
radiological worsening of pre-existing tuberculous lesions or
the development of new lesions not attributable to the
normal course of disease, in a patient who initially improved
with antimycobacterial therapy (Fig. 7). Up to 10% of
patients with CNS TB report paradoxical responses, and this
number may be as high as 30% in HIV-infected patients.51,52
Conclusions
Only 5e10% of immunocompetent children progress from
TB infection to disease. Risks of progression to disease are
dependent upon host factors such as patient age and
immune status. The most common sites of infection are the
lung and superficial lymph nodes in children. Rapidly
progressive forms of disease include CNS involvement anddisseminated (miliary) TB; later complications include
skeletal and renal disease. Childhood TB is associated with
relatively lower culture yields than in adults; the diagnosis
is often based on a positive skin test, epidemiological risk
factors, and clinical presentations.References
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